Direct Peritoneal Resuscitation from Hypovolemic Shock
Direct Peritoneal Resuscitation from Hypovolemic Shock
批准号:
6848037
负责人:
Richard N Garrison
金额:
$22.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-01 至 2008-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The pathophysiology of Hemorrhagic shock consists of disruption of the cellular metabolic functions endothelial barrier properties, redistribution of body fluids and electrolytes, a systemic inflammatory response, and a deleterious intestinal vasoconstriction and a disproportionate splanchnic hypoperfusion, which persists even after adequate fluid replacement that restores and maintains hemodynamics. These pathophysiologic events cause local and remote tissue injury that culminates in multiple organ failure (MOF) by mechanisms, which are poorly understood. It is hypothesize that initiation of direct intraperitoneal resuscitation (DPR) with a balanced physiologic salt solution supplemented with glucose (2.5%), at the time of conventional resuscitation (CR) from hemorrhagic shock can reverse the pathophysiology of this syndrome, improving resuscitation outcome, potentially preventing (MOF) and improving survival: a) by suppressing the hemorrhage-induced systemic inflammatory response, b) by direct intestinal resuscitation to enhance visceral perfusion and cardiac output, c) by improving endothelial cell responsiveness, to vasodilators, and d) by preventing the hemorrhage-induced water and electrolytes imbalance. To address this hypothesis, we will utilize intravital microscopy, and quantitative autoradiography (QAR) to perform in vivo studies in a rodent model of hemorrhagic shock, which will be resuscitated with either CR or CR+DPR and determine the following: 1) Serum cytokines profile and level of prostanoid metabolites; 2) Endothelial cell function with dose-response curves to endothelial-dependent, receptor-mediated and non-receptor mediated as well as endothelial-independent agonists; 3) The pattern of distribution of tissue water (intravascular thetaiv, interstitial thetaif, intracellular thetaic) in the gut and abdominal wall with QAR; 4) The role of neutrophils in the derangement of intestinal microvascular endothelium by measuring microvascular responses in the presence of anti-PMN serum and specific antibodies; and 5) The mechanisms involved in the ability of DPR to reverse the pathophysiology of the shock syndrome. Long-term objectives are to develop a pre-clinical protocol that utilizes DPR as a prelude to translation of the results to trauma patients and finally a clinical protocol that utilize DPR to prevent multiple organ failure in hemorrhage shock with resuscitation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Direct Peritoneal Resuscitation from Hypovolemic Shock
-
批准号:7062138
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2004
-
负责人:Richard N Garrison
-
依托单位:
Direct Peritoneal Resuscitation from Hypovolemic Shock
-
批准号:6754143
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2004
-
负责人:Richard N Garrison
-
依托单位:
Direct Peritoneal Resuscitation from Hypovolemic Shock
-
批准号:7189031
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2004
-
负责人:Richard N Garrison
-
依托单位:
MICROVASCULAR CONTROL BY TISSUE FACTORS IN SEPSIS
-
批准号:3132792
-
项目类别:
-
资助金额:$8.49万
-
财政年份:1986
-
负责人:Richard N Garrison
-
依托单位:
MICROVASCULAR CONTROL BY TISSUE FACTORS IN SEPSIS
-
批准号:3132791
-
项目类别:
-
资助金额:$8.62万
-
财政年份:1986
-
负责人:Richard N Garrison
-
依托单位:
MICROVASCULAR CONTROL BY TISSUE FACTORS IN SEPSIS
-
批准号:3132786
-
项目类别:
-
资助金额:$7.24万
-
财政年份:1986
-
负责人:Richard N Garrison
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: